138 related articles for article (PubMed ID: 12911586)
1. Alpha2-antiplasmin plays a significant role in acute pulmonary embolism.
Matsuno H; Okada K; Ueshima S; Matsuo O; Kozawa O
J Thromb Haemost; 2003 Aug; 1(8):1734-9. PubMed ID: 12911586
[TBL] [Abstract][Full Text] [Related]
2. Plasmin generation plays different roles in the formation and removal of arterial and venous thrombus in mice.
Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
Thromb Haemost; 2002 Jan; 87(1):98-104. PubMed ID: 11848464
[TBL] [Abstract][Full Text] [Related]
3. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
Singh S; Houng A; Reed GL
Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
[TBL] [Abstract][Full Text] [Related]
4. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.
Nagai N; De Mol M; Lijnen HR; Carmeliet P; Collen D
Circulation; 1999 May; 99(18):2440-4. PubMed ID: 10318667
[TBL] [Abstract][Full Text] [Related]
5. Alpha2-antiplasmin on cardiovascular diseases.
Matsuno H
Curr Pharm Des; 2006; 12(7):841-7. PubMed ID: 16515500
[TBL] [Abstract][Full Text] [Related]
6. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction.
Matsuno H; Kozawa O; Yoshimi N; Akamatsu S; Hara A; Mori H; Okada K; Ueshima S; Matsuo O; Uematsu T
Blood; 2002 Oct; 100(7):2487-93. PubMed ID: 12239160
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of fibrinolytic components play different roles in the formation and removal of arterial thrombus in mice.
Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
J Cardiovasc Pharmacol; 2002 Feb; 39(2):278-86. PubMed ID: 11791014
[TBL] [Abstract][Full Text] [Related]
8. Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi.
Shaya SA; Gani DM; Weitz JI; Kim PY; Gross PL
Thromb Haemost; 2019 Jun; 119(6):992-999. PubMed ID: 31005064
[TBL] [Abstract][Full Text] [Related]
9. Reversing the deleterious effects of α2-antiplasmin on tissue plasminogen activator therapy improves outcomes in experimental ischemic stroke.
Houng AK; Wang D; Reed GL
Exp Neurol; 2014 May; 255():56-62. PubMed ID: 24556477
[TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator plasma levels as a potential diagnostic aid in acute pulmonary embolism.
Flores J; García-Avello A; Flores VM; Navarro JL; Canseco F; Pérez-Rodríguez E
Arch Pathol Lab Med; 2003 Mar; 127(3):310-5. PubMed ID: 12653574
[TBL] [Abstract][Full Text] [Related]
11. Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1.
Dewerchin M; Collen D; Lijnen HR
Thromb Haemost; 2001 Aug; 86(2):640-6. PubMed ID: 11522016
[TBL] [Abstract][Full Text] [Related]
12. The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism.
Reed GL; Houng AK
Circulation; 1999 Jan; 99(2):299-304. PubMed ID: 9892598
[TBL] [Abstract][Full Text] [Related]
13. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.
Okada K; Ueshima S; Tanaka M; Fukao H; Matsuo O
Blood Coagul Fibrinolysis; 2000 Oct; 11(7):645-55. PubMed ID: 11085285
[TBL] [Abstract][Full Text] [Related]
14. Endogenous alpha2-antiplasmin does not enhance glomerular fibrin deposition or injury in glomerulonephritis.
Kitching AR; Turner AL; O'Sullivan KM; Dewerchin M; Lijnen HR
J Thromb Haemost; 2003 Sep; 1(9):1992-9. PubMed ID: 12941042
[TBL] [Abstract][Full Text] [Related]
15. Lack of plasminogen activator inhibitor-1 enhances the preventive effect of DX-9065a, a selective factor Xa inhibitor, on venous thrombus and acute pulmonary embolism in mice.
Shu E; Matsuno H; Ishisaki A; Kitajima Y; Kozawa O
Pathophysiol Haemost Thromb; 2003 Jul-2004 Aug; 33(4):206-13. PubMed ID: 15583451
[TBL] [Abstract][Full Text] [Related]
16. Venous stasis-induced fibrinolysis prevents thrombosis in mice: role of α2-antiplasmin.
Singh S; Houng AK; Reed GL
Blood; 2019 Sep; 134(12):970-978. PubMed ID: 31395599
[TBL] [Abstract][Full Text] [Related]
17. Effective lysis of model thrombi by a t-PA mutant (A473S) that is resistant to alpha2-antiplasmin.
Robbie LA; Bennett B; Keyt BA; Booth NA
Br J Haematol; 2000 Nov; 111(2):517-23. PubMed ID: 11122093
[TBL] [Abstract][Full Text] [Related]
18. Lack of alpha 2-antiplasmin enhances ADP induced platelet micro-aggregation through the presence of excess active plasmin in mice.
Takei M; Matsuno H; Okada K; Ueshima S; Matsuo O; Kozawa O
J Thromb Thrombolysis; 2002 Dec; 14(3):205-11. PubMed ID: 12913400
[TBL] [Abstract][Full Text] [Related]
19. Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding.
Lijnen HR; Okada K; Matsuo O; Collen D; Dewerchin M
Blood; 1999 Apr; 93(7):2274-81. PubMed ID: 10090937
[TBL] [Abstract][Full Text] [Related]
20. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
Nielsen VG
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
